Enwei Pharmaceutical 配当金
配当金 基準チェック /16
Enwei Pharmaceutical is a dividend paying company with a current yield of 2.12%.
主要情報
2.1%
配当利回り
1.3%
バイバック利回り
| 総株主利回り | 3.4% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | CN¥0.540 |
| 配当性向 | 156% |
決済の安定と成長
配当データの取得
安定した配当: Too early to tell whether 301331's dividend payments have been stable as they only just started paying a dividend.
増加する配当: Too early to tell if 301331's dividend payments are increasing as they only just started paying a dividend.
配当利回り対市場
| Enwei Pharmaceutical 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (301331) | 2.1% |
| 市場下位25% (CN) | 0.6% |
| 市場トップ25% (CN) | 2.2% |
| 業界平均 (Pharmaceuticals) | 1.7% |
| アナリスト予想 (301331) (最長3年) | n/a |
注目すべき配当: 301331's dividend (2.12%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
高配当: 301331's dividend (2.12%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
株主への利益配当
収益カバレッジ: With its high payout ratio (156.1%), 301331's dividend payments are not well covered by earnings.
株主配当金
キャッシュフローカバレッジ: 301331 is paying a dividend but the company has no free cash flows.